Section Arrow
Quote
SGMO.OOTC
- Sangamo Therapeutics, Inc.
Quotes are at least 15-min delayed:2026/05/13 16:54 EDT
After Hours
Last
 --
-- (--)
Bid
--
Ask
--
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 0.1424
+0.006 (+4.40%)
Day High 
0.154675 
Prev. Close
0.1364 
1-M High
0.295 
Volume 
5.03M 
Bid
--
Ask
--
Day Low
0.1295 
Open
0.1522 
1-M Low
0.1 
Market Cap 
56.51M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.13 
20-SMA 0.19 
50-SMA 0.27 
52-W High 0.766 
52-W Low 0.1 
Exchange OOTC 
Valuation Estimation
EPS (Current/Estimated)
-0.44/0.39
Enterprise Value
56.51M
Balance Sheet
Book Value Per Share
-0.03
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
--
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
No related information.
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its neurology development is focused on two areas: development of epigenetic regulation therapies to treat serious neurological diseases and development of novel engineered adeno-associated virus, or AAV, capsids to deliver its therapies to the intended neurological targets. The group's pipeline products are Small Fiber Neuropathy, Prion Disease, Tauopathies, ALS/FTD, Huntington's Disease, Fabry Disease, and Hemophilia A.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.